Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,259 | -4,463 | -3,975 | -2,928 | -8,281 |
| Depreciation Amortization | 201 | 323 | 217 | 103 | 380 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 116 |
| Accounts receivable | N/A | N/A | N/A | N/A | 229 |
| Other Working Capital | -408 | -101 | -164 | -339 | 491 |
| Other Operating Activity | 3,657 | 3,133 | 2,755 | 2,208 | 2,879 |
| Operating Cash Flow | $-1,809 | $-1,107 | $-1,167 | $-956 | $-4,187 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -21 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -339 |
| Other Investing Activity | 0 | -457 | -502 | 0 | 0 |
| Investing Cash Flow | $N/A | $-457 | $-502 | $N/A | $-360 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 30 | 30 | 30 | 30 | N/A |
| Debt Issued | 942 | 282 | 282 | 282 | 1,463 |
| Debt Repayment | -327 | -179 | 738 | N/A | N/A |
| Common Stock Issued | 1,373 | 1,296 | 525 | 394 | 3,456 |
| Common Stock Repurchased | -7 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -29 | 216 | 152 | 218 | -1,049 |
| Financing Cash Flow | $1,981 | $1,645 | $1,726 | $924 | $3,870 |
| Exchange Rate Effect | -25 | -28 | -32 | -26 | 2 |
| Beginning Cash Position | 717 | 717 | 717 | 717 | 1,392 |
| End Cash Position | 864 | 770 | 743 | 659 | 717 |
| Net Cash Flow | $147 | $53 | $26 | $-58 | $-675 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,809 | -1,107 | -1,167 | -956 | -4,187 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -21 |
| Free Cash Flow | -1,809 | -1,107 | -1,167 | -956 | -4,208 |